{
    "2019-09-06": [
        [
            {
                "time": "",
                "original_text": "[快讯]健帆生物:关于部分董事及监事减持计划实施完毕 拟减持股份",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "董事",
                        "监事",
                        "减持计划",
                        "实施完毕"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "健帆生物：部分董事及监事累计减持0.29%股份，完成减持计划 减持股份",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "董事",
                        "监事",
                        "累计减持",
                        "0.29%"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "健帆生物(300529.SZ)：李得志及方丽华减持计划实施完毕 合计减持142.84万股 拟减持股份",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "李得志",
                        "方丽华",
                        "减持计划",
                        "实施完毕",
                        "142.84万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}